[{"id":"c9fa59c0-ee9b-4c5f-baf7-8f04f47fe653","acronym":"","url":"https://clinicaltrials.gov/study/NCT05630794","created_at":"2022-11-30T18:57:52.049Z","updated_at":"2025-02-25T13:41:21.187Z","phase":"Phase 1","brief_title":"Testing ONC201 to Prevent Colorectal Cancer","source_id_and_acronym":"NCT05630794","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" BCL2 • IL6 • TNFA • IL10 • CASP3 • GZMA • IL17A • PRL","pipe":"","alterations":" ","tags":["BCL2 • IL6 • TNFA • IL10 • CASP3 • GZMA • IL17A • PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Modeyso (dordaviprone)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 03/30/2025","start_date":" 03/30/2025","primary_txt":" Primary completion: 01/01/2026","primary_completion_date":" 01/01/2026","study_txt":" Completion: 01/01/2028","study_completion_date":" 01/01/2028","last_update_posted":"2025-02-21"},{"id":"e94eda48-02c6-40bc-8f38-bdeb553754b5","acronym":"CASE6119","url":"https://clinicaltrials.gov/study/NCT04674306","created_at":"2021-01-19T20:45:27.933Z","updated_at":"2025-02-25T15:18:56.819Z","phase":"Phase 1","brief_title":"Adjuvant Therapy with an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer","source_id_and_acronym":"NCT04674306 - CASE6119","lead_sponsor":"George T. Budd","biomarkers":" HER-2 • ER • PGR • BRCA1 • PRL","pipe":" | ","alterations":" HER-2 negative • PALB2 mutation • ER negative","tags":["HER-2 • ER • PGR • BRCA1 • PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PALB2 mutation • ER negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e alpha-lactalbumin vaccine"],"overall_status":"Recruiting","enrollment":" Enrollment 45","initiation":"Initiation: 10/01/2021","start_date":" 10/01/2021","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2025-02-12"},{"id":"7b6a4335-88ee-4c63-a5cb-29fd6154bfa1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05822817","created_at":"2023-04-21T15:04:19.078Z","updated_at":"2024-07-02T16:35:06.715Z","phase":"Phase 4","brief_title":"Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery","source_id_and_acronym":"NCT05822817","lead_sponsor":"Peking Union Medical College Hospital","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"],"overall_status":"Recruiting","enrollment":" Enrollment 252","initiation":"Initiation: 05/03/2023","start_date":" 05/03/2023","primary_txt":" Primary completion: 04/01/2024","primary_completion_date":" 04/01/2024","study_txt":" Completion: 04/01/2024","study_completion_date":" 04/01/2024","last_update_posted":"2024-05-01"},{"id":"9461158e-5d26-4049-990e-1b882bc14200","acronym":"","url":"https://clinicaltrials.gov/study/NCT06295952","created_at":"2024-03-06T21:33:56.543Z","updated_at":"2024-07-02T16:35:06.703Z","phase":"Phase 2","brief_title":"A Study of Pasireotide in People With Prolactinoma","source_id_and_acronym":"NCT06295952","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Signifor (pasireotide)"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 02/27/2024","start_date":" 02/27/2024","primary_txt":" Primary completion: 02/01/2027","primary_completion_date":" 02/01/2027","study_txt":" Completion: 02/01/2027","study_completion_date":" 02/01/2027","last_update_posted":"2024-05-01"},{"id":"2abc8b5e-bbff-4610-b944-f367032e5447","acronym":"","url":"https://clinicaltrials.gov/study/NCT06156020","created_at":"2023-12-09T16:35:00.738Z","updated_at":"2024-07-02T16:35:13.394Z","phase":"","brief_title":"Outcome Analysis of Endoscopic Resection of Pituitary Adenomas","source_id_and_acronym":"NCT06156020","lead_sponsor":"National Cheng-Kung University Hospital","biomarkers":" IGF1 • PRL","pipe":"","alterations":" ","tags":["IGF1 • PRL"],"overall_status":"Recruiting","enrollment":" Enrollment 500","initiation":"Initiation: 01/01/2020","start_date":" 01/01/2020","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-03-21"},{"id":"d6659ed0-a160-442d-9ebc-6110d6f497a3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03161652","created_at":"2022-07-22T08:56:46.266Z","updated_at":"2024-07-02T16:35:39.044Z","phase":"Phase 2","brief_title":"Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema","source_id_and_acronym":"NCT03161652","lead_sponsor":"Carmen Clapp","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lucentis (ranibizumab)"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 05/24/2017","start_date":" 05/24/2017","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-08-25"},{"id":"a1bef58e-86d0-4a4c-8e69-93297872915f","acronym":"QLARITY","url":"https://clinicaltrials.gov/study/NCT03749109","created_at":"2021-01-18T18:23:01.954Z","updated_at":"2024-07-02T16:35:40.789Z","phase":"Phase 2","brief_title":"Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis","source_id_and_acronym":"NCT03749109 - QLARITY","lead_sponsor":"Ferring Pharmaceuticals","biomarkers":" IGF1 • PRL","pipe":"","alterations":" ","tags":["IGF1 • PRL"],"overall_status":"Completed","enrollment":" Enrollment 67","initiation":"Initiation: 08/19/2019","start_date":" 08/19/2019","primary_txt":" Primary completion: 06/21/2021","primary_completion_date":" 06/21/2021","study_txt":" Completion: 07/18/2021","study_completion_date":" 07/18/2021","last_update_posted":"2023-08-07"},{"id":"e1bc5a7a-72a6-4415-994b-32196310a76f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04495985","created_at":"2022-07-22T08:58:27.893Z","updated_at":"2024-07-02T16:35:43.782Z","phase":"","brief_title":"CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer","source_id_and_acronym":"NCT04495985","lead_sponsor":"The Cleveland Clinic","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 39","initiation":"Initiation: 07/14/2020","start_date":" 07/14/2020","primary_txt":" Primary completion: 07/27/2022","primary_completion_date":" 07/27/2022","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2023-07-06"},{"id":"34eceedd-bc69-4ed1-bbff-0cc66fe8b494","acronym":"","url":"https://clinicaltrials.gov/study/NCT05005715","created_at":"2021-08-13T12:53:42.468Z","updated_at":"2024-07-02T16:36:26.358Z","phase":"Phase 2","brief_title":"Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery","source_id_and_acronym":"NCT05005715","lead_sponsor":"Seoul National University Hospital","biomarkers":" IGF1 • PRL","pipe":"","alterations":" ","tags":["IGF1 • PRL"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 64","initiation":"Initiation: 08/30/2021","start_date":" 08/30/2021","primary_txt":" Primary completion: 08/29/2022","primary_completion_date":" 08/29/2022","study_txt":" Completion: 08/29/2023","study_completion_date":" 08/29/2023","last_update_posted":"2021-08-13"},{"id":"2aff72cf-f476-43a2-9bd8-ff5d943c1d1f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04708093","created_at":"2022-07-22T08:58:37.228Z","updated_at":"2024-07-02T16:36:36.085Z","phase":"","brief_title":"Whole Body Vibration Training and Breast Cancer Risk Factors","source_id_and_acronym":"NCT04708093","lead_sponsor":"Cairo University","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 08/01/2019","start_date":" 08/01/2019","primary_txt":" Primary completion: 08/01/2020","primary_completion_date":" 08/01/2020","study_txt":" Completion: 09/01/2020","study_completion_date":" 09/01/2020","last_update_posted":"2021-01-13"},{"id":"1d2806c4-6266-4455-9731-65d694163d34","acronym":"","url":"https://clinicaltrials.gov/study/NCT00601289","created_at":"2021-01-18T02:13:42.025Z","updated_at":"2024-07-02T16:36:42.548Z","phase":"Phase 2","brief_title":"Temozolomide in Treating Patients With Invasive Pituitary Tumors","source_id_and_acronym":"NCT00601289","lead_sponsor":"Jonsson Comprehensive Cancer Center","biomarkers":" IGF1 • PRL","pipe":"","alterations":" ","tags":["IGF1 • PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 12/01/2009","start_date":" 12/01/2009","primary_txt":" Primary completion: 10/01/2010","primary_completion_date":" 10/01/2010","study_txt":"","study_completion_date":"","last_update_posted":"2020-07-31"},{"id":"7f03c3f7-74dd-4581-a823-0407a28b50a5","acronym":"","url":"https://clinicaltrials.gov/study/NCT03457389","created_at":"2021-01-18T17:02:43.890Z","updated_at":"2024-07-02T16:36:48.260Z","phase":"","brief_title":"Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma","source_id_and_acronym":"NCT03457389","lead_sponsor":"Seoul National University Hospital","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"],"overall_status":"Recruiting","enrollment":" Enrollment 68","initiation":"Initiation: 02/22/2018","start_date":" 02/22/2018","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2020-03-18"},{"id":"8007afed-268d-497a-ba52-ede17e61fe90","acronym":"","url":"https://clinicaltrials.gov/study/NCT03904368","created_at":"2022-07-22T08:58:03.046Z","updated_at":"2024-07-02T16:37:00.856Z","phase":"","brief_title":"The Value of Myomectomy in Women With Intramural Myoma Before IVF.","source_id_and_acronym":"NCT03904368","lead_sponsor":"Cairo University","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"],"overall_status":"Unknown status","enrollment":" Enrollment 100","initiation":"Initiation: 04/01/2019","start_date":" 04/01/2019","primary_txt":" Primary completion: 12/01/2020","primary_completion_date":" 12/01/2020","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2019-04-05"},{"id":"09359f46-0ac9-4649-abb8-2c92744c542f","acronym":"","url":"https://clinicaltrials.gov/study/NCT03714763","created_at":"2021-02-09T07:58:47.369Z","updated_at":"2024-07-02T16:37:05.869Z","phase":"","brief_title":"Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)","source_id_and_acronym":"NCT03714763","lead_sponsor":"Zhebao Wu","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"],"overall_status":"Unknown status","enrollment":" Enrollment 50","initiation":"Initiation: 11/01/2018","start_date":" 11/01/2018","primary_txt":" Primary completion: 11/30/2021","primary_completion_date":" 11/30/2021","study_txt":" Completion: 01/31/2022","study_completion_date":" 01/31/2022","last_update_posted":"2018-10-22"},{"id":"5c198dbc-6083-4c67-b2d1-7c3c064510c7","acronym":"","url":"https://clinicaltrials.gov/study/NCT01620138","created_at":"2021-02-09T07:54:52.437Z","updated_at":"2024-07-02T16:37:29.629Z","phase":"Phase 2/3","brief_title":"Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas","source_id_and_acronym":"NCT01620138","lead_sponsor":"Universidade Federal do Rio de Janeiro","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Signifor (pasireotide)"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 03/01/2010","start_date":" 03/01/2010","primary_txt":" Primary completion: 06/01/2012","primary_completion_date":" 06/01/2012","study_txt":" Completion: 06/01/2012","study_completion_date":" 06/01/2012","last_update_posted":"2016-08-22"}]